BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-257@pharmaconomics
DTSTAMP:20260707T033826Z
DTSTART;VALUE=DATE:20260630
DTEND;VALUE=DATE:20260701
SUMMARY:CLNN AdCom — CNM-Au8 (estimated date)
DESCRIPTION:An FDA advisory committee reviews CNM-Au8 for amyotrophic lateral sclerosis (ALS) around ~ Jun 30\, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1822791/000143774926014542/clnn20260503_8k.htm\n\nTrack it: https://pharmaconomics.com/e/257
URL:https://pharmaconomics.com/e/257
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CLNN catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR